Epsilon M&A Deal Report - Harlan Sprague Dawley
Transaction Multiples for the Valuation of Private Companies
Private Group led by Genstar Capital LLC / Harlan Sprague Dawley
No EMAT :
72762
Announced Date :
31/10/2005
Type :
LBO (Leverage Buy Out)
Deal Value :
Yes
Acquirer :
Private Group led by Genstar Capital LLC
Target :
Harlan Sprague Dawley
Country :
United States
Sector of activity :
- Laboratories > Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Biomedical Research Laboratory
Business Description :
Founded in 1931, Harlan Sprague Dawley Inc. is a provider of research models and services and pre-clinical services for drug discovery and development . > Serves over 1,600 customers, including some...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
||||||
| Current |
Rating :
*
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Biomedical Research Laboratory » = 34
| Date | Acquirer | Target | Country | Multiples | See details |
| 11/06/2015 | Altan Pharma | GES Group | Spain | ** | 72544 |
| 16/06/2015 | Private Group led by HLD, UI Gestion and DV France | IP Santé Domicile (IPS) | France | * | 72339 |
Source: Epsilon Research / EMAT
